Pharmacodynamic/Pharmacokinetic Study of AQW051 in Schizophrenia
Clinical trial NCT00825539 · COMPLETED
Trial details
- NCT number
- NCT00825539
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2011-11-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.